Skip to main content

Advertisement

Log in

Infusion of Mesenchymal Stem Cells Protects Lung Transplants from Cold Ischemia-Reperfusion Injury in Mice

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Background

Cold ischemia-reperfusion injury (IRI) is a major cause of graft failure in lung transplantation. Despite therapeutic benefits of mesenchymal stem cells (MSCs) in attenuating acute lung injury, their protection of lung transplants from cold IRI remains elusive. The present study was to test the efficacy of MSCs in the prevention of cold IRI using a novel murine model of orthotopic lung transplantation.

Methods

Donor lungs from C57BL/6 mice were exposed to 6 h of cold ischemia before transplanted to syngeneic recipients. MSCs were isolated from the bone marrows of C57BL/6 mice for recipient treatment. Gas exchange was determined by the measurement of blood oxygenation, and lung injury and inflammation were assessed by histological analyses.

Results

Intravenously delivered MSC migration/trafficking to the lung grafts occurred within 4-hours post-transplantation. As compared to untreated controls, the graft arterial blood oxygenation (PaO2/FiO2) capacity was significantly improved in MSC-treated recipients as early as 4 h post-reperfusion and such improvement continued over time. By 72 h, oxygenation reached normal level that was not seen in controls. MSCs treatment conferred significant protection of the grafts from cold IRI and cell apoptosis, which is correlated with less cellular infiltration, a decrease in proinflammatory cytokines (TNF-α, IL-6) and toll-like receptor 4, and an increase in anti-inflammatory TSG-6 generation.

Conclusions

MSCs provide significant protection against cold IRI in lung transplants, and thus may be a promising strategy to improve outcomes after lung transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ANOVA:

Analysis of variance

eGFF:

Enhanced green fluorescence protein

H&E:

Hematoxylin & eosin

MSCs:

Mesenchymal stem cells

IL:

Interleukin

IRI:

Ischemia-reperfusion injury

ROS:

Reactive oxygen species

SEM:

Standard error of mean

TNF:

Tumor necrosis factor

TLR:

Toll-like receptor

TSG:

Tumor necrosis factor-α stimulated gene/protein

TUNEL:

Terminal deoxynucleotyl transferase dUTP nick end labeling

References

  1. Bittner HB, Binner C, Dahlberg P, Mohr FW (2007) Reducing ischemia-reperfusion injury in clinical lung transplantation. Transplant Proc 39(2):489–492. doi:10.1016/j.transproceed.2006.12.005

    Article  CAS  PubMed  Google Scholar 

  2. Fischer S, Cassivi SD, Xavier AM, Cardella JA, Cutz E, Edwards V, Liu M, Keshavjee S (2000) Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg 231(3):424–431

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL (2010) Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 299(5):H1283–1299. doi:10.1152/ajpheart.00251.2010

    Article  Google Scholar 

  4. Weyker PD, Webb CA, Kiamanesh D, Flynn BC (2013) Lung ischemia reperfusion injury: a bench-to-bedside review. Semin Cardiothorac Vasc Anesth 17(1):28–43. doi:10.1177/1089253212458329

    Article  PubMed  Google Scholar 

  5. Yip HK, Chang YC, Wallace CG, Chang LT, Tsai TH, Chen YL, Chang HW, Leu S, Zhen YY, Tsai CY, Yeh KH, Sun CK, Yen CH (2013) Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury. J Pineal Res 54(2):207–221. doi:10.1111/jpi.12020

    Article  CAS  PubMed  Google Scholar 

  6. Souidi N, Stolk M, Seifert M (2013) Ischemia-reperfusion injury: beneficial effects of mesenchymal stromal cells. Curr Opin Organ Transplant 18(1):34–43. doi:10.1097/MOT.0b013e32835c2a05

    Article  CAS  PubMed  Google Scholar 

  7. Manning E, Pham S, Li S, Vazquez-Padron RI, Mathew J, Ruiz P, Salgar SK (2010) Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther 21(6):713–727. doi:10.1089/hum.2009.147

    Article  CAS  PubMed  Google Scholar 

  8. Svobodova E, Krulova M, Zajicova A, Pokorna K, Prochazkova J, Trosan P, Holan V (2012) The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population. Stem Cells Dev 21(6):901–910. doi:10.1089/scd.2011.0157

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Dimarino AM, Caplan AI, Bonfield TL (2013) Mesenchymal stem cells in tissue repair. Front Immunol 4:201. doi:10.3389/fimmu.2013.00201

    Article  PubMed Central  PubMed  Google Scholar 

  10. De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, Pascual CY, Aller MA, Arias J, Arnalich-Montiel F (2012) Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 12(5):574–591

    Article  PubMed  Google Scholar 

  11. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA (2009) Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11(4):377–391. doi:10.1080/14653240903080367

    Article  CAS  PubMed  Google Scholar 

  12. Assis AC, Carvalho JL, Jacoby BA, Ferreira RL, Castanheira P, Diniz SO, Cardoso VN, Goes AM, Ferreira AJ (2010) Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant 19(2):219–230. doi:10.3727/096368909X479677

    Article  PubMed  Google Scholar 

  13. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5(1):54–63. doi:10.1016/j.stem.2009.05.003

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108(7):863–868. doi:10.1161/01.CIR.0000084828.50310.6A

    Article  PubMed  Google Scholar 

  15. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18(5):683–692. doi:10.1089/scd.2008.0253

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Ge W, Jiang J, Baroja ML, Arp J, Zassoko R, Liu W, Bartholomew A, Garcia B, Wang H (2009) Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 9(8):1760–1772. doi:10.1111/j.1600-6143.2009.02721.x

    Article  CAS  PubMed  Google Scholar 

  17. Jungraithmayr WM, Korom S, Hillinger S, Weder W (2009) A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 137(2):486–491. doi:10.1016/j.jtcvs.2008.10.007

    Article  PubMed  Google Scholar 

  18. Chen S, Chen L, Wu X, Lin J, Fang J, Chen X, Wei S, Xu J, Gao Q, Kang M (2012) Ischemia postconditioning and mesenchymal stem cells engraftment synergistically attenuate ischemia reperfusion-induced lung injury in rats. J Surg Res 178(1):81–91. doi:10.1016/j.jss.2012.01.039

    Article  CAS  PubMed  Google Scholar 

  19. Prakash A, Mesa KR, Wilhelmsen K, Xu F, Dodd-o JM, Hellman J (2012) Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in mice. Anesthesiology 117(4):822–835. doi:10.1097/ALN.0b013e31826a4ae3

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Zanotti G, Casiraghi M, Abano JB, Tatreau JR, Sevala M, Berlin H, Smyth S, Funkhouser WK, Burridge K, Randell SH, Egan TM (2009) Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol 297(1):L52–63. doi:10.1152/ajplung.90406.2008

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Getting SJ, Mahoney DJ, Cao T, Rugg MS, Fries E, Milner CM, Perretti M, Day AJ (2002) The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner. J Biol Chem 277(52):51068–51076. doi:10.1074/jbc.M205121200

    Article  CAS  PubMed  Google Scholar 

  22. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 118(2):330–338. doi:10.1182/blood-2010-12-327353

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Sun CK, Yen CH, Lin YC, Tsai TH, Chang LT, Kao YH, Chua S, Fu M, Ko SF, Leu S, Yip HK (2011) Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. J Transl Med 9:118. doi:10.1186/1479-5876-9-118

    Article  PubMed Central  PubMed  Google Scholar 

  24. Reis A, Giaid A, Serrick C, Shennib H (1995) Improved outcome of rat lung transplantation with modification of the nonsuture external cuff technique. J Heart Lung Transplant 14(2):274–279

    CAS  PubMed  Google Scholar 

  25. Okazaki M, Krupnick AS, Kornfeld CG, Lai JM, Ritter JH, Richardson SB, Huang HJ, Das NA, Patterson GA, Gelman AE, Kreisel D (2007) A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant 7(6):1672–1679. doi:10.1111/j.1600-6143.2007.01819.x

    Article  CAS  PubMed  Google Scholar 

  26. Krupnick AS, Lin X, Li W, Okazaki M, Lai J, Sugimoto S, Richardson SB, Kornfeld CG, Garbow JR, Patterson GA, Gelman AE, Kreisel D (2009) Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc 4(1):86–93. doi:10.1038/nprot.2008.218

    Article  CAS  PubMed  Google Scholar 

  27. Sugimoto R, Tanaka Y, Noda K, Kawamura T, Toyoda Y, Billiar TR, McCurry KR, Nakao A (2012) Preservation solution supplemented with biliverdin prevents lung cold ischaemia/reperfusion injury. Eur J Cardiothorac Surg 42(6):1035–1041. doi:10.1093/ejcts/ezs298

    Article  PubMed  Google Scholar 

  28. Kreisel D, Goldstein DR (2013) Innate immunity and organ transplantation: focus on lung transplantation. Transpl Int 26(1):2–10. doi:10.1111/j.1432-2277.2012.01549.x

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Diamond JM, Wigfield CH (2013) Role of innate immunity in primary graft dysfunction after lung transplantation. Curr Opin Organ Transplant. doi:10.1097/MOT.0b013e3283651994

    PubMed  Google Scholar 

  30. Kaczorowski DJ, Nakao A, Mollen KP, Vallabhaneni R, Sugimoto R, Kohmoto J, Tobita K, Zuckerbraun BS, McCurry KR, Murase N, Billiar TR (2007) Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 84(10):1279–1287. doi:10.1097/01.tp.0000287597.87571.17

    Article  CAS  PubMed  Google Scholar 

  31. Ben DF, Yu XY, Ji GY, Zheng DY, Lv KY, Ma B, Xia ZF (2012) TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. J Surg Res 174(2):326–333. doi:10.1016/j.jss.2010.12.005

    Article  CAS  PubMed  Google Scholar 

  32. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8(9):726–736. doi:10.1038/nri2395

    Article  CAS  PubMed  Google Scholar 

  33. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94(5):678–685. doi:10.1161/01.RES.0000118601.37875.AC

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to Dr. Bertha Garcia at Western University, London, Canada for her critical review of the histological slides, and to Drs. Shuhua Luo and Weihua Liu for their technical assistance. This work was supported by Grant to H.W. from National Natural Science Foundation of China (No. 81273257), and National High Technology Research and Development Program 863 (2012AA021003). C.D. was supported by grants from the Kidney Foundation of Canada and the Canadian Institutes of Health Research.

Conflict of interest

The authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Caigan Du or Hao Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tian, W., Liu, Y., Zhang, B. et al. Infusion of Mesenchymal Stem Cells Protects Lung Transplants from Cold Ischemia-Reperfusion Injury in Mice. Lung 193, 85–95 (2015). https://doi.org/10.1007/s00408-014-9654-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-014-9654-x

Keywords

Navigation